Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05316506
Other study ID # 20211092
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2022
Est. completion date September 1, 2023

Study information

Verified date September 2023
Source University of Miami
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research is to look at the impact that phrases of likely discomfort or a description of the procedure have on the perception of pain during in-office hysteroscopy.


Recruitment information / eligibility

Status Completed
Enrollment 70
Est. completion date September 1, 2023
Est. primary completion date September 1, 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: 1. Adults 18 years of age and older 2. Scheduled for in office hysteroscopy 3. Able to consent for the study in English or Spanish Exclusion Criteria: 1. Persons with preexisting conditions that may alter pain perception (ie. active vulvo-vaginal infection, vulvodynia, genital lesions, chronic pain conditions) 2. Previous in-office hysteroscopy 3. Hysteroscopy for foreign body/ Intrauterine Device (IUD) removal 4. Minors, prisoners, or other members of vulnerable populations 5. Patients who cannot communicate in English or Spanish

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Anticipated Discomfort Language
This language involves pain descriptors provided from physician to patient during procedure.
Objective Descriptive Language
This language involves neutral/objective descriptors provided from physician to patients during procedure.

Locations

Country Name City State
United States University of Miami Hospital Miami Florida

Sponsors (1)

Lead Sponsor Collaborator
University of Miami

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Pain as measured by Visual Analog Scale (VAS) Pain will be assessed using the Visual Analog Scale (VAS). Visual Analog Scale (VAS) is score from 0 (no pain) to 10 (worst pain imaginable). Baseline (pre-procedure), Day 1 (post-procedure)
Secondary Number of participants in each pain category Number of participants reporting actual pain compared to their anticipated the pain post procedure.
Pain Free
Less painful than anticipated
As painful as anticipated
More painful than anticipated
Much more painful than anticipated
Day 1 (post-procedure)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04614688 - Assessing the Impact of a Patient Education Platform to Augment the Informed Consent Process for Obstetrics and Gynecology Procedures N/A